Abiopharma

🔍 SHORT JAY M PHD (Executive)

Company: BioAtla, Inc. (BCAB)

Report Date: 2026-03-11

Detailed Transactions and Holdings:

• Acquired 430,000 shares of Common Stock (Direct)
  Date: 2026-03-11 | Code: A | equity_swap_involved: false | shares_owned_after: 2,659,603.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-11 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 793,547.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-11 | Code: H | nature_of_ownership: By Carolyn Short 2020 Irrevocable Gift Trust | shares_owned_after: 258,727.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-11 | Code: H | nature_of_ownership: By Jay Short 2020 Irrevocable Gift Trust | shares_owned_after: 258,727.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-11 | Code: H | nature_of_ownership: By Capia IP, LLC | shares_owned_after: 302,324.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-11 | Code: H | nature_of_ownership: By Himalaya Parent LLC | shares_owned_after: 50.00 | Footnotes: F2

Footnotes:

• F1: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 11, 2027, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February, subject to the reporting person's continued service through the applicable vesting date.
• F2: The Reporting Person and his spouse are the managers of Himalaya Parent LLC and collectively make investment decisions on the behalf of the entity. The Reporting Person and his spouse disclaim beneficial ownership of the reported securities except to the extent of his or her pecuniary interest therein.